SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Nephrology Consultation — Ida B. Wells

PatientIda B. Wells
Date of birth1957-07-16
IdentifiersMRN HR-ET022-SYN; SSN (made up) 000-22-5903
Document date2026-01-20
AuthorEmeka Lindqvist-Moore, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Reason for Referral

New chronic kidney disease, probably G3b A2, of uncertain cause in a 68-year-old Black woman with tiredness, ankle swelling and high blood pressure readings: race-free eGFR 40 by creatinine and 38 with cystatin C, and a urine albumin-to-creatinine ratio of 240 mg/g. Please advise on the cause and further evaluation, APOL1 genetic testing, kidney-protective treatment and its order, the anemia and mineral findings, and how and when to plan for the future. [S]

Urgency: Within two weeks, on the day of her two-week visit, after the repeat urine test and the kidney ultrasound. [S]

Questions for the consultant:

History of Present Illness

Mrs. Wells, 68, is seen at the request of Dr. Ashworth-Banks for chronic kidney disease found two weeks ago. She has been tired for some months and has had ankle swelling by evening. She took naproxen for knee aching for about a year and stopped it two weeks ago. She has no diabetes, no visible blood in the urine, no foamy urine, no rash, joint swelling or mouth ulcers, and no history of kidney stones or urinary infections. She brought an outside report from two years ago: creatinine 1.05 mg/dL with an eGFR of 64 reported as normal, from an equation with a race coefficient. Her home blood pressure average over seven days is 150/88. She asked detailed questions and wants the evidence behind each recommendation. [S]

Historical basis. These claims are historical evidence, not findings from a modern examination.

2 later historical claims are omitted because they describe events after the index age. See the teaching note.

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Medications

MedicationFrequencyRouteDatesStatusEvidence
Acetaminophen 500 mg oral tablet, one or two tablets up to three times a day as needed for knee aching (no more than 3,000 mg a day), in place of naproxenOne or two tablets up to three times a day as neededOral route2026-01-05activeS
Losartan 50 mg oral tablet, one tablet daily; hold on days of vomiting, diarrhea or not eatingOne tablet daily, with sick-day rulesOral route2026-01-20 to 2026-03-03completedS
Atorvastatin 20 mg oral tablet, one tablet dailyOne tablet dailyOral route2026-01-20activeS
Cholecalciferol (vitamin D3) 25 mcg (1,000 units) oral tablet, one tablet dailyOne tablet dailyOral route2026-01-20activeS

Problems

ProblemClinical statusVerificationCodeProvenance
Tiredness for some months and ankle swelling by evening, with a raised creatinine (1.42 mg/dL, race-free eGFR 40, confirmed at 38 with cystatin C) and albumin in the urine (240 mg/g) found today; cause and chronicity to be establishedresolvedconfirmed R94.4S — Synthetic presenting finding, superseded by the kidney diagnosis at two weeks.
Elevated blood pressure at intake (164/94 mmHg, average of two readings), without a diagnosis of hypertension; home readings for one week to confirmresolvedconfirmed R03.0S — Synthetic presenting finding, superseded by the confirmed diagnosis at two weeks.
Hypertension, stage 2, confirmed by home readings (average 150/88 mmHg), with chronic kidney diseaseactiveconfirmed I12.9S — Synthetic modern diagnosis; no blood pressure from her life is recorded.
Chronic kidney disease G3b A2 (eGFR 38 by creatinine and cystatin C, urine albumin-to-creatinine ratio 240 and 228 mg/g), present at least two years; small, echogenic kidneys without obstruction; most likely hypertensive kidney disease, with APOL1-associated disease possible; 5-year kidney failure risk about 7%activeconfirmed N18.32S — Synthetic modern diagnosis linked to the kidney disease recorded at her death.
Anemia of chronic kidney disease, mild (hemoglobin 11.2 g/dL) with adequate iron stores; a likely part of her tirednessactiveconfirmed D63.1S — Synthetic laboratory finding.
Vitamin D deficiency (25-hydroxyvitamin D 17 ng/mL) with a mildly raised PTH (84 pg/mL); calcium and phosphate normalactiveconfirmed E55.9S — Synthetic laboratory finding, part of the mineral and bone check in kidney disease.

Physical Exam

Vital signs recorded on 2026-01-20; see the referring visit's Vital Signs section. [S]

SystemFinding
Vital signsBlood pressure 154/90 and pulse 76, measured in clinic today
CardiovascularRegular rhythm; no rub; trace ankle swelling
Skin and jointsNo rash; no joint swelling

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-01-20Albumin/Creatinine [Mass Ratio] in Urine228mg/gBelow 30 mg/g normal (A1); 30 to 300 moderately increased (A2); above 300 severely increased (A3)HighS

Assessment

Data reviewed: Intake results as listed by Dr. Ashworth-Banks. Recalculated earlier value: eGFR 59 by the race-free CKD-EPI 2021 equation (64 by the older race-based equation). Today's results by the older equation would read 44. Urine albumin-to-creatinine ratio 228 mg/g today (240 at intake). Urinalysis: 1+ protein, no blood, no casts; bland sediment. Serum protein electrophoresis: no monoclonal protein; free light chain ratio 1.2, normal for her eGFR. Hepatitis B surface antigen, hepatitis C antibody and HIV negative; hepatitis B surface antibody negative. Kidney ultrasound this morning: right kidney 9.6 cm, left 9.4 cm, both echogenic with thinned cortex, no hydronephrosis, stones or masses. ECG with voltage criteria for left ventricular hypertrophy. Kidney failure risk equation: about 7% at 5 years, 2% at 2 years. [S]

Plan of Treatment